Novo Nordisk ADR

NVONYSE · USD
39.13USD0.00 (+0.21%)
1085

Novo Nordisk ADR (NVO) Straddle

NVO straddle scan found 315 qualifying long straddle setups on the previous trading day. Probability of profit reaches up to 56.0%.

Read more

Trading a NVO straddle lets you take a pure volatility position on Novo Nordisk ADR without committing to a direction. Novo Nordisk ADR's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate NVO straddle pricing in real time and find the moments when expected moves are mispriced.

A long straddle on NVO profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when Novo Nordisk ADR stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the NVO straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides insulin pens, growth hormone pens, and injection needles.

In addition, it offers smart solutions for diabetes treatment, such as smart insulin pens and Dose Check, an insulin dose guidance application. The company has a collaboration agreement with UNICEF to tackle childhood obesity; and with Valo Health, Inc. to discover and develop novel drug programmes for cardiometabolic space. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

Earnings, product cycles, macro prints — any time volatility itself is the trade, the NVO straddle is the cleanest expression of that view. Our scanner prices every NVO straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a NVO straddle into a catalyst or short a NVO straddle to harvest decay, the options straddle setups that matter are all in one place.

Oct 30, 202639.00$1.26740%56.0%$40.26$37.74870
Oct 30, 202639.50$1.31740%55.8%$40.81$38.19186
Jan 21, 202860.00$22.3245540%55.0%$82.32$37.691,474
Dec 17, 202785.00$45.9942040%54.3%$130.99$39.021
Dec 15, 202875.00$38.1978440%54.3%$113.19$36.8142
Dec 17, 202790.00$50.9842040%54.3%$140.98$39.020
Jan 19, 202965.00$29.8081940%54.2%$94.80$35.2023
Dec 17, 202770.00$31.4442040%54.1%$101.44$38.571,038
Dec 15, 202870.00$33.9978440%53.8%$103.99$36.0211
Jan 21, 202865.00$27.1445540%53.8%$92.14$37.87321

As of October 26, 2026

Find the right straddle before volatility moves

Track NVO straddle pricing across expirations, filter by IV rank and breakeven points, and build a setup that fits your view before the move happens.

Start your 14-day free trial